Sumary of ASX dives 1.3%, ASIC sues ANZ, CBA raises mortgage rates again:
- Australian investors shouldn’t expect a repeat of the mammoth payouts they received in the 2021 financial year, with post-COVID market volatility and weaker iron ore prices likely to make companies more cautious on dividends.
- With research from asset manager Janus Henderson this month highlighting that Australian payouts grew four times faster than the rest of the world, hitting a record of $41.9 billion in the third quarter of 2021, experts are warning of a more subdued outlook for the 2022 financial year.
- High iron ore prices drove mining giants’ massive payouts in the 2021 financial year.
- Read the full story hereLocal prescription software startup MedAdvisor will double down on capturing US market share as pharmacies emerge from the COVID crunch.
- “There’s no doubt that COVID has been a massive distraction in the US, particularly in the pharmacy market.
- “Medadvisor has also recently launched $US3 million pilot in the US to reach out to patients in areas of low COVID-19 vaccination to encourage them to book in.
- The tech giants that Appen relies on for 80 per cent of its business, are moving the work inhouse, according to Macquarie.
- “This will be a structural change in our view which on balance will result in less annotation market share for external annotation vendors (including APX) and has resulted in our downgrade of earnings forecasts beyond FY21.” This is the fear which has seen the stock shredded in value since trading as high as $45 last year.